Immix Biopharma, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KImmix Biopharma, Inc.IMMXSep 30

   Current report

2. ROUTINEFWPImmix Biopharma, Inc.IMMXSep 29

   2 structured-note prospectuses

   Securities offering

   Show all 2

   • FWPSecurities offeringSep 29
   • 424B5Securities offeringSep 29
3. ROUTINE8-KImmix Biopharma, Inc.IMMXSep 29

   Current report

4. ROUTINESCHEDULE 13GImmix Biopharma, Inc.IMMXAug 14

   Ownership stake disclosure by EVENTIDE ASSET MANAGEMENT, LLC

   EVENTIDE ASSET MANAGEMENT, LLC, filed by

5. ROUTINESCHEDULE 13G/AImmix Biopharma, Inc.IMMXAug 13

   Ownership stake disclosure by Janus Henderson Group Ltd. (amended)

   Janus Henderson Group Ltd., filed by

6. NOTABLE10-QImmix Biopharma, Inc.IMMXAug 7

   Quarterly report

7. ROUTINE8-KImmix Biopharma, Inc.IMMXJul 20

   Current report

8. ROUTINESCHEDULE 13G/AImmix Biopharma, Inc.IMMXJun 5

   Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)

   JANUS HENDERSON GROUP PLC, filed by

9. ROUTINE8-KImmix Biopharma, Inc.IMMXMay 29

   Current report

10. ROUTINE4Immix Biopharma, Inc.IMMXMay 29

    9 insider filings

    Nancy T Chang, insider filing for IMMX

    Show all 9

    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29
    • 4Insider filing for IMMXMay 29

    Nancy T Chang, reporting

11. ROUTINE8-KImmix Biopharma, Inc.IMMXMay 21

    Current report

12. ROUTINE424B5Immix Biopharma, Inc.IMMXMay 21

    Securities offering

13. ROUTINEFWPImmix Biopharma, Inc.IMMXMay 21

    Securities offering

14. ROUTINE8-KImmix Biopharma, Inc.IMMXMay 21

    Current report

15. ROUTINESCHEDULE 13G/AImmix Biopharma, Inc.IMMXMay 15

    Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)

    JANUS HENDERSON GROUP PLC, filed by

16. NOTABLE10-QImmix Biopharma, Inc.IMMXMay 7

    Quarterly report

17. ROUTINESCHEDULE 13G/AImmix Biopharma, Inc.IMMXMay 4

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC (amended)

    MILLENNIUM MANAGEMENT LLC, filed by

18. ROUTINEARSImmix Biopharma, Inc.IMMXApr 6

    Annual report to shareholders

19. ROUTINEDEFA14AImmix Biopharma, Inc.IMMXApr 6

    Additional proxy materials

20. ROUTINEDEF 14AImmix Biopharma, Inc.IMMXApr 6

    Proxy statement

21. ROUTINE8-KImmix Biopharma, Inc.IMMXMar 30

    Current report

22. ROUTINE10-K/AImmix Biopharma, Inc.IMMXMar 27

    Annual report (amended)

23. ROUTINES-8Immix Biopharma, Inc.IMMXMar 25

    Employee stock plan registration

24. ROUTINE8-KImmix Biopharma, Inc.IMMXMar 25

    Current report

25. ROUTINE424B5Immix Biopharma, Inc.IMMXMar 25

    Securities offering

26. NOTABLE10-KImmix Biopharma, Inc.IMMXMar 25

    Annual report

27. ROUTINESCHEDULE 13GImmix Biopharma, Inc.IMMXMar 20

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC

    MILLENNIUM MANAGEMENT LLC, filed by

28. ROUTINESCHEDULE 13GImmix Biopharma, Inc.IMMXFeb 17

    Ownership stake disclosure by Saturn V Capital Management LP

    Saturn V Capital Management LP, filed by

29. ROUTINESCHEDULE 13GImmix Biopharma, Inc.IMMXFeb 17

    Ownership stake disclosure by JANUS HENDERSON GROUP PLC

    JANUS HENDERSON GROUP PLC, filed by

30. ROUTINEEFFECTImmix Biopharma, Inc.IMMXJan 23

    Registration declared effective

31. ROUTINES-3Immix Biopharma, Inc.IMMXJan 9

    Securities offering

32. ROUTINE4Immix Biopharma, Inc.IMMXDec 11, 2025

    Nancy T Chang, insider filing for IMMX

    Nancy T Chang, reporting

33. ROUTINE4Immix Biopharma, Inc.IMMXDec 10, 2025

    2 insider filings

    Ilya M Rachman, insider filing for IMMX

    Show all 2

    • 4Insider filing for IMMXDec 10, 2025
    • 4Insider filing for IMMXDec 10, 2025

    Ilya M Rachman, reporting

34. ROUTINE8-KImmix Biopharma, Inc.IMMXDec 8, 2025

    Current report

35. ROUTINE424B5Immix Biopharma, Inc.IMMXDec 8, 2025

    Securities offering

36. ROUTINEFWPImmix Biopharma, Inc.IMMXDec 8, 2025

    Securities offering

37. ROUTINE8-KImmix Biopharma, Inc.IMMXDec 8, 2025

    Current report

38. ROUTINEEFFECTImmix Biopharma, Inc.IMMXDec 2, 2025

    Registration declared effective

39. ROUTINE8-KImmix Biopharma, Inc.IMMXNov 26, 2025

    Current report

40. NOTABLE10-QImmix Biopharma, Inc.IMMXNov 7, 2025

    Quarterly report

Older filings on EDGAR